Concept Medical (MagicTouch PTA 0.035 OTW) receives CE ... | 合法醫療器材資訊網

MagicTouchPTApreventsthere-narrowingofsuperficialfemoralandpoplitealarteriesinpatientswithperipheralarterydisease.Anexcellentalternativefor ...

Concept Medical[1] has been granted “CE Certification” for Magic Touch PTA 0.035 OTW (Percutaneous Transluminal Angioplasty) its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease.

MagicTouch PTA[2] prevents the re-narrowing of superficial femoral and popliteal arteries in patients with peripheral artery disease. An excellent alternative for revascularization of peripheral arteries.

The catheter is intended to treat patients with peripheral artery disease (PAD). It is based on the company’s Nanolute Technology sirolimus drug delivery platform.

Concept Medical has pioneered the Sirolimus drug delivery platform technology (Nanolute Technology[3]), which has a proven commercial history in the coronary applications in more than 30,000 patients worldwide. MagicTouch PTA Sirolimus coated balloon is developed using this Nanolut...